You are here

Menarini

Lupin acquires five brands and associated trademark rights from Menarini

Pharmaceutical Business Review

Mon, 09/25/23 - 11:42 am

Menarini shows Big Pharma how it's done with first approval for oral SERD drug in breast cancer

Fierce Pharma

Mon, 01/30/23 - 05:50 pm

As Sanofi's SERD falls, Menarini’s advances with EU review

Fierce Biotech

Fri, 08/19/22 - 10:42 am

Menarini Diagnostics’ New COVID-19 Test Detects Variants Including Omicron

Xtalks

Fri, 01/21/22 - 10:58 am

Omicron COVID-19 variant

Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA

Fierce Biotech

Thu, 10/21/21 - 10:35 am

clinical trials

Biopharma takeovers show quantity, if not quality

EP Vantage

Mon, 07/13/20 - 11:13 am

Gilead Sciences

Portola Pharmaceuticals

Stemline Therapeutics

Tetra Therapeutics

How the pandemic helped secure a rare cancer drug for Menarini

Endpoints

Thu, 05/14/20 - 11:53 am

Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M

Xconomy

Mon, 05/4/20 - 10:35 pm

Stemline Therapeutics

Drug Deal Can Only Help VIVUS So Much

Motley Fool

Thu, 07/11/13 - 10:35 am

erectile dysfunction

Vivus signs impotence drug deal as proxy vote looms

Reuters

Tue, 07/9/13 - 05:11 pm

erectile dysfunction